WTW announces fourth quarter earnings per share of $2.75 for 2011

NewsGuard 100/100 Score
Yesterday, Weight Watchers (WTW) announced fourth quarter earnings that were 14% higher than expectations with earnings of $.64 compared to the consensus of $.56.  Moreover, forward guidance showed earnings per share (EPS) of $2.75 for 2011, but Weight Watchers (WTW) now forecasts that EPS would be between $3.50 and $3.85 for the coming year.

The news sent the stock price of Weight Watchers (WTW) skyrocketing as the stock gapped up from a closing price of $44.92 on Wednesday to an opening price of $59.00 on Thursday, eventually reaching a high of $66.22.

Zacks Investment Research anticipated this move on Wednesday when one of its premium subscription services made a buy recommendation on Weight Watchers (WTW).  Editor and Analyst, Mike Vodicka, explains, "We believed that Weight Watchers (WTW) would have a strong announcement when we observed that the 30-day consensus was trending higher than the full consensus.  This indicated that more bullish estimates were preceding the report."

Called Zacks Whisper Trader, this premium service has predicted positive earnings surprises with 77.96% accuracy.

Whisper Trader is presently closed to new members, but has established a Waiting List of investors to be notified when spots open up.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies